Regulation of vascular endothelial junction stability and remodeling through Rap1-Rasip1 signaling

References

• Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473:298 - 307; http://dx.doi.org/10.1038/nature10144; PMID: 21593862
   PubMed Web of Science ®Google Scholar
• Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 2011; 27:563 - 84; http://dx.doi.org/10.1146/annurev-cellbio-092910-154002; PMID: 21756109
   PubMed Web of Science ®Google Scholar
• Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci 2010; 51:2813 - 26; http://dx.doi.org/10.1167/iovs.10-5176; PMID: 20484600
   PubMed Web of Science ®Google Scholar
• Konisti S, Kiriakidis S, Paleolog EM. Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 2012; 8:153 - 62; http://dx.doi.org/10.1038/nrrheum.2011.205; PMID: 22293762
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350:2335 - 42; http://dx.doi.org/10.1056/NEJMoa032691; PMID: 15175435
   PubMed Web of Science ®Google Scholar
• Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, Shenkier T, Cella D, Davidson NE. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 2007; 357:2666 - 76; http://dx.doi.org/10.1056/NEJMoa072113; PMID: 18160686
   PubMed Web of Science ®Google Scholar
• Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006; 355:2542 - 50; http://dx.doi.org/10.1056/NEJMoa061884; PMID: 17167137
   PubMed Web of Science ®Google Scholar
• Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 2012; 320:130 - 7; http://dx.doi.org/10.1016/j.canlet.2012.03.008; PMID: 22425960
   PubMed Web of Science ®Google Scholar
• Schlingemann RO, Witmer AN. Treatment of retinal diseases with VEGF antagonists. Prog Brain Res 2009; 175:253 - 67; http://dx.doi.org/10.1016/S0079-6123(09)17517-9; PMID: 19660661
   PubMed Web of Science ®Google Scholar
• Vestweber D. Novel insights into leukocyte extravasation. Curr Opin Hematol 2012; 19:212 - 7; http://dx.doi.org/10.1097/MOH.0b013e3283523e78; PMID: 22395664
   PubMed Web of Science ®Google Scholar
• Dejana E, Giampietro C. Vascular endothelial-cadherin and vascular stability. Curr Opin Hematol 2012; 19:218 - 23; http://dx.doi.org/10.1097/MOH.0b013e3283523e1c; PMID: 22395663
   PubMed Web of Science ®Google Scholar
• Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, Ferrarini L, Orsenigo F, Papa E, Boulday G, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 2013; 498:492 - 6; http://dx.doi.org/10.1038/nature12207; PMID: 23748444
   PubMed Web of Science ®Google Scholar
• Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 2009; 17:860 - 71; http://dx.doi.org/10.1038/ejhg.2009.35; PMID: 19337313
   PubMed Web of Science ®Google Scholar
• Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009; 16:209 - 21; http://dx.doi.org/10.1016/j.devcel.2009.01.004; PMID: 19217423
   PubMed Web of Science ®Google Scholar
• Takai Y, Miyoshi J, Ikeda W, Ogita H. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 2008; 9:603 - 15; http://dx.doi.org/10.1038/nrm2457; PMID: 18648374
   PubMed Web of Science ®Google Scholar
• Shapiro L, Weis WI. Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol 2009; 1:a003053; http://dx.doi.org/10.1101/cshperspect.a003053; PMID: 20066110
   PubMed Web of Science ®Google Scholar
• Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 2005; 123:903 - 15; http://dx.doi.org/10.1016/j.cell.2005.09.021; PMID: 16325583
   PubMed Web of Science ®Google Scholar
• Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the cadherin-catenin-actin complex. Cell 2005; 123:889 - 901; http://dx.doi.org/10.1016/j.cell.2005.09.020; PMID: 16325582
   PubMed Web of Science ®Google Scholar
• Oas RG, Nanes BA, Esimai CC, Vincent PA, García AJ, Kowalczyk AP. p120-catenin and β-catenin differentially regulate cadherin adhesive function. Mol Biol Cell 2013; 24:704 - 14; http://dx.doi.org/10.1091/mbc.E12-06-0471; PMID: 23325790
   PubMed Web of Science ®Google Scholar
• Kourtidis A, Ngok SP, Anastasiadis PZ. p120 catenin: an essential regulator of cadherin stability, adhesion-induced signaling, and cancer progression. Prog Mol Biol Transl Sci 2013; 116:409 - 32; http://dx.doi.org/10.1016/B978-0-12-394311-8.00018-2; PMID: 23481205
   PubMed Web of Science ®Google Scholar
• Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, Frank R, Muller WA, Hicklin DJ, Bohlen P, Dejana E. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 2001; 97:1679 - 84; http://dx.doi.org/10.1182/blood.V97.6.1679; PMID: 11238107
   PubMed Web of Science ®Google Scholar
• Gotsch U, Borges E, Bosse R, Böggemeyer E, Simon M, Mossmann H, Vestweber D. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 1997; 110:583 - 8; PMID: 9092940
   PubMed Web of Science ®Google Scholar
• Schulte D, Küppers V, Dartsch N, Broermann A, Li H, Zarbock A, Kamenyeva O, Kiefer F, Khandoga A, Massberg S, et al. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J 2011; 30:4157 - 70; http://dx.doi.org/10.1038/emboj.2011.304; PMID: 21857650
   PubMed Web of Science ®Google Scholar
• Strilić B, Kucera T, Eglinger J, Hughes MR, McNagny KM, Tsukita S, Dejana E, Ferrara N, Lammert E. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 2009; 17:505 - 15; http://dx.doi.org/10.1016/j.devcel.2009.08.011; PMID: 19853564
   PubMed Web of Science ®Google Scholar
• Lampugnani MG, Orsenigo F, Rudini N, Maddaluno L, Boulday G, Chapon F, Dejana E. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 2010; 123:1073 - 80; http://dx.doi.org/10.1242/jcs.059329; PMID: 20332120
   PubMed Web of Science ®Google Scholar
• Dejana E, Orsenigo F. Endothelial adherens junctions at a glance. J Cell Sci 2013; 126:2545 - 9; http://dx.doi.org/10.1242/jcs.124529; PMID: 23781019
   PubMed Web of Science ®Google Scholar
• Fernández-Martín L, Marcos-Ramiro B, Bigarella CL, Graupera M, Cain RJ, Reglero-Real N, Jiménez A, Cernuda-Morollón E, Correas I, Cox S, et al. Crosstalk between reticular adherens junctions and platelet endothelial cell adhesion molecule-1 regulates endothelial barrier function. Arterioscler Thromb Vasc Biol 2012; 32:e90 - 102; http://dx.doi.org/10.1161/ATVBAHA.112.252080; PMID: 22723439
   PubMedGoogle Scholar
• Huveneers S, Oldenburg J, Spanjaard E, van der Krogt G, Grigoriev I, Akhmanova A, Rehmann H, de Rooij J. Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling. J Cell Biol 2012; 196:641 - 52; http://dx.doi.org/10.1083/jcb.201108120; PMID: 22391038
   PubMed Web of Science ®Google Scholar
• Millán J, Cain RJ, Reglero-Real N, Bigarella C, Marcos-Ramiro B, Fernández-Martín L, Correas I, Ridley AJ. Adherens junctions connect stress fibres between adjacent endothelial cells. BMC Biol 2010; 8:11; http://dx.doi.org/10.1186/1741-7007-8-11; PMID: 20122254
   PubMed Web of Science ®Google Scholar
• Hoelzle MK, Svitkina T. The cytoskeletal mechanisms of cell-cell junction formation in endothelial cells. Mol Biol Cell 2012; 23:310 - 23; http://dx.doi.org/10.1091/mbc.E11-08-0719; PMID: 22090347
   PubMed Web of Science ®Google Scholar
• Huveneers S, de Rooij J. Mechanosensitive systems at the cadherin-F-actin interface. J Cell Sci 2013; 126:403 - 13; http://dx.doi.org/10.1242/jcs.109447; PMID: 23524998
   PubMed Web of Science ®Google Scholar
• Yonemura S, Wada Y, Watanabe T, Nagafuchi A, Shibata M. alpha-Catenin as a tension transducer that induces adherens junction development. Nat Cell Biol 2010; 12:533 - 42; http://dx.doi.org/10.1038/ncb2055; PMID: 20453849
   PubMed Web of Science ®Google Scholar
• Calderwood DA, Campbell ID, Critchley DR. Talins and kindlins: partners in integrin-mediated adhesion. Nat Rev Mol Cell Biol 2013; 14:503 - 17; http://dx.doi.org/10.1038/nrm3624; PMID: 23860236
   PubMed Web of Science ®Google Scholar
• Frische EW, Zwartkruis FJ. Rap1, a mercenary among the Ras-like GTPases. Dev Biol 2010; 340:1 - 9; http://dx.doi.org/10.1016/j.ydbio.2009.12.043; PMID: 20060392
   PubMed Web of Science ®Google Scholar
• Cherfils J, Zeghouf M. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev 2013; 93:269 - 309; http://dx.doi.org/10.1152/physrev.00003.2012; PMID: 23303910
   PubMed Web of Science ®Google Scholar
• Pannekoek WJ, Kooistra MR, Zwartkruis FJ, Bos JL. Cell-cell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim Biophys Acta 2009; 1788:790 - 6; http://dx.doi.org/10.1016/j.bbamem.2008.12.010; PMID: 19159611
   PubMed Web of Science ®Google Scholar
• Chrzanowska-Wodnicka M. Regulation of angiogenesis by a small GTPase Rap1. Vascul Pharmacol 2010; 53:1 - 10; http://dx.doi.org/10.1016/j.vph.2010.03.003; PMID: 20302970
   PubMed Web of Science ®Google Scholar
• Yan J, Li F, Ingram DA, Quilliam LA. Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions. Mol Cell Biol 2008; 28:5803 - 10; http://dx.doi.org/10.1128/MCB.00393-08; PMID: 18625726
   PubMed Web of Science ®Google Scholar
• Li Y, Yan J, De P, Chang HC, Yamauchi A, Christopherson KW 2nd, Paranavitana NC, Peng X, Kim C, Munugalavadla V, et al. Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. J Immunol 2007; 179:8322 - 31; PMID: 18056377
   PubMed Web of Science ®Google Scholar
• Duchniewicz M, Zemojtel T, Kolanczyk M, Grossmann S, Scheele JS, Zwartkruis FJ. Rap1A-deficient T and B cells show impaired integrin-mediated cell adhesion. Mol Cell Biol 2006; 26:643 - 53; http://dx.doi.org/10.1128/MCB.26.2.643-653.2006; PMID: 16382154
   PubMed Web of Science ®Google Scholar
• Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM, Fischer TH, White GC 2nd. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest 2005; 115:680 - 7; http://dx.doi.org/10.1172/JCI22973; PMID: 15696195
   PubMed Web of Science ®Google Scholar
• Chrzanowska-Wodnicka M, Kraus AE, Gale D, White GC 2nd, Vansluys J. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 2008; 111:2647 - 56; http://dx.doi.org/10.1182/blood-2007-08-109710; PMID: 17993608
   PubMed Web of Science ®Google Scholar
• Lakshmikanthan S, Sobczak M, Chun C, Henschel A, Dargatz J, Ramchandran R, Chrzanowska-Wodnicka M. Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃. Blood 2011; 118:2015 - 26; http://dx.doi.org/10.1182/blood-2011-04-349282; PMID: 21636859
   PubMed Web of Science ®Google Scholar
• Chrzanowska-Wodnicka M. Distinct functions for Rap1 signaling in vascular morphogenesis and dysfunction. Exp Cell Res 2013; 319:2350 - 9; http://dx.doi.org/10.1016/j.yexcr.2013.07.022; PMID: 23911990
   PubMed Web of Science ®Google Scholar
• Carmona G, Göttig S, Orlandi A, Scheele J, Bäuerle T, Jugold M, Kiessling F, Henschler R, Zeiher AM, Dimmeler S, et al. Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis. Blood 2009; 113:488 - 97; http://dx.doi.org/10.1182/blood-2008-02-138438; PMID: 18805968
   PubMed Web of Science ®Google Scholar
• Hong J, Doebele RC, Lingen MW, Quilliam LA, Tang WJ, Rosner MR. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J Biol Chem 2007; 282:19781 - 7; http://dx.doi.org/10.1074/jbc.M700128200; PMID: 17491018
   PubMed Web of Science ®Google Scholar
• de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998; 396:474 - 7; http://dx.doi.org/10.1038/24884; PMID: 9853756
   PubMed Web of Science ®Google Scholar
• Kooistra MR, Corada M, Dejana E, Bos JL. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 2005; 579:4966 - 72; http://dx.doi.org/10.1016/j.febslet.2005.07.080; PMID: 16115630
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 2005; 25:136 - 46; http://dx.doi.org/10.1128/MCB.25.1.136-146.2005; PMID: 15601837
   PubMed Web of Science ®Google Scholar
• Wittchen ES, Worthylake RA, Kelly P, Casey PJ, Quilliam LA, Burridge K. Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J Biol Chem 2005; 280:11675 - 82; http://dx.doi.org/10.1074/jbc.M412595200; PMID: 15661741
   PubMed Web of Science ®Google Scholar
• Pannekoek WJ, van Dijk JJ, Chan OY, Huveneers S, Linnemann JR, Spanjaard E, Brouwer PM, van der Meer AJ, Zwartkruis FJ, Rehmann H, et al. Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction control. Cell Signal 2011; 23:2056 - 64; http://dx.doi.org/10.1016/j.cellsig.2011.07.022; PMID: 21840392
   PubMed Web of Science ®Google Scholar
• Birukova AA, Zagranichnaya T, Fu P, Alekseeva E, Chen W, Jacobson JR, Birukov KG. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Exp Cell Res 2007; 313:2504 - 20; http://dx.doi.org/10.1016/j.yexcr.2007.03.036; PMID: 17493609
   PubMed Web of Science ®Google Scholar
• Wilson CW, Parker LH, Hall CJ, Smyczek T, Mak J, Crow A, Posthuma G, De Mazière A, Sagolla M, Chalouni C, et al. Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signaling. Blood 2013; 122:3678 - 90; http://dx.doi.org/10.1182/blood-2013-02-483156; PMID: 23886837
   PubMed Web of Science ®Google Scholar
• Wittchen ES, Aghajanian A, Burridge K. Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions. Small GTPases 2011; 2:65 - 76; http://dx.doi.org/10.4161/sgtp.2.2.15735; PMID: 21776404
   PubMedGoogle Scholar
• Smutny M, Cox HL, Leerberg JM, Kovacs EM, Conti MA, Ferguson C, Hamilton NA, Parton RG, Adelstein RS, Yap AS. Myosin II isoforms identify distinct functional modules that support integrity of the epithelial zonula adherens. Nat Cell Biol 2010; 12:696 - 702; http://dx.doi.org/10.1038/ncb2072; PMID: 20543839
   PubMed Web of Science ®Google Scholar
• Takai Y, Ikeda W, Ogita H, Rikitake Y. The immunoglobulin-like cell adhesion molecule nectin and its associated protein afadin. Annu Rev Cell Dev Biol 2008; 24:309 - 42; http://dx.doi.org/10.1146/annurev.cellbio.24.110707.175339; PMID: 18593353
   PubMed Web of Science ®Google Scholar
• Tawa H, Rikitake Y, Takahashi M, Amano H, Miyata M, Satomi-Kobayashi S, Kinugasa M, Nagamatsu Y, Majima T, Ogita H, et al. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis. Circ Res 2010; 106:1731 - 42; http://dx.doi.org/10.1161/CIRCRESAHA.110.216747; PMID: 20413783
   PubMed Web of Science ®Google Scholar
• Ikeda W, Nakanishi H, Miyoshi J, Mandai K, Ishizaki H, Tanaka M, Togawa A, Takahashi K, Nishioka H, Yoshida H, et al. Afadin: A key molecule essential for structural organization of cell-cell junctions of polarized epithelia during embryogenesis. J Cell Biol 1999; 146:1117 - 32; http://dx.doi.org/10.1083/jcb.146.5.1117; PMID: 10477764
   PubMed Web of Science ®Google Scholar
• Majima T, Takeuchi K, Sano K, Hirashima M, Zankov DP, Tanaka-Okamoto M, Ishizaki H, Miyoshi J, Ogita H. An Adaptor Molecule Afadin Regulates Lymphangiogenesis by Modulating RhoA Activity in the Developing Mouse Embryo. PLoS One 2013; 8:e68134; http://dx.doi.org/10.1371/journal.pone.0068134; PMID: 23840823
   PubMed Web of Science ®Google Scholar
• Zhadanov AB, Provance DW Jr., Speer CA, Coffin JD, Goss D, Blixt JA, Reichert CM, Mercer JA. Absence of the tight junctional protein AF-6 disrupts epithelial cell-cell junctions and cell polarity during mouse development. Curr Biol 1999; 9:880 - 8; http://dx.doi.org/10.1016/S0960-9822(99)80392-3; PMID: 10469590
   PubMed Web of Science ®Google Scholar
• Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 1997; 15:1043 - 9; http://dx.doi.org/10.1038/sj.onc.1201268; PMID: 9285558
   PubMed Web of Science ®Google Scholar
• Béraud-Dufour S, Gautier R, Albiges-Rizo C, Chardin P, Faurobert E. Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1. FEBS J 2007; 274:5518 - 32; http://dx.doi.org/10.1111/j.1742-4658.2007.06068.x; PMID: 17916086
   PubMed Web of Science ®Google Scholar
• Glading A, Han J, Stockton RA, Ginsberg MH. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 2007; 179:247 - 54; http://dx.doi.org/10.1083/jcb.200705175; PMID: 17954608
   PubMed Web of Science ®Google Scholar
• Stockton RA, Shenkar R, Awad IA, Ginsberg MH. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 2010; 207:881 - 96; http://dx.doi.org/10.1084/jem.20091258; PMID: 20308363
   PubMed Web of Science ®Google Scholar
• Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC. Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 2001; 10:2953 - 60; http://dx.doi.org/10.1093/hmg/10.25.2953; PMID: 11741838
   PubMed Web of Science ®Google Scholar
• Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 2004; 131:1437 - 48; http://dx.doi.org/10.1242/dev.01036; PMID: 14993192
   PubMed Web of Science ®Google Scholar
• Mitin NY, Ramocki MB, Zullo AJ, Der CJ, Konieczny SF, Taparowsky EJ. Identification and characterization of rain, a novel Ras-interacting protein with a unique subcellular localization. J Biol Chem 2004; 279:22353 - 61; http://dx.doi.org/10.1074/jbc.M312867200; PMID: 15031288
   PubMed Web of Science ®Google Scholar
• Xu K, Chong DC, Rankin SA, Zorn AM, Cleaver O. Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation. Dev Biol 2009; 329:269 - 79; http://dx.doi.org/10.1016/j.ydbio.2009.02.033; PMID: 19272373
   PubMed Web of Science ®Google Scholar
• Xu K, Sacharidou A, Fu S, Chong DC, Skaug B, Chen ZJ, Davis GE, Cleaver O. Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling. Dev Cell 2011; 20:526 - 39; http://dx.doi.org/10.1016/j.devcel.2011.02.010; PMID: 21396893
   PubMed Web of Science ®Google Scholar
• Post A, Pannekoek WJ, Ross SH, Verlaan I, Brouwer PM, Bos JL. Rasip1 mediates Rap1 regulation of Rho in endothelial barrier function through ArhGAP29. Proc Natl Acad Sci U S A 2013; 110:11427 - 32; http://dx.doi.org/10.1073/pnas.1306595110; PMID: 23798437
   PubMed Web of Science ®Google Scholar
• Ando K, Fukuhara S, Moriya T, Obara Y, Nakahata N, Mochizuki N. Rap1 potentiates endothelial cell junctions by spatially controlling myosin II activity and actin organization. J Cell Biol 2013; 202:901 - 16; http://dx.doi.org/10.1083/jcb.201301115; PMID: 24019534
   PubMed Web of Science ®Google Scholar
• Smolen GA, Schott BJ, Stewart RA, Diederichs S, Muir B, Provencher HL, Look AT, Sgroi DC, Peterson RT, Haber DA. A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors. Genes Dev 2007; 21:2131 - 6; http://dx.doi.org/10.1101/gad.1561507; PMID: 17704304
   PubMed Web of Science ®Google Scholar
• Yan J, Mei FC, Cheng H, Lao DH, Hu Y, Wei J, Patrikeev I, Hao D, Stutz SJ, Dineley KT, et al. Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1. Mol Cell Biol 2013; 33:918 - 26; http://dx.doi.org/10.1128/MCB.01227-12; PMID: 23263987
   PubMed Web of Science ®Google Scholar
• Kai AK, Lam AK, Chen Y, Tai AC, Zhang X, Lai AK, Yeung PK, Tam S, Wang J, Lam KS, et al. Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome. FASEB J 2013; 27:4122 - 35; http://dx.doi.org/10.1096/fj.13-230433; PMID: 23825225
   PubMed Web of Science ®Google Scholar
• Sehrawat S, Cullere X, Patel S, Italiano J Jr., Mayadas TN. Role of Epac1, an exchange factor for Rap GTPases, in endothelial microtubule dynamics and barrier function. Mol Biol Cell 2008; 19:1261 - 70; http://dx.doi.org/10.1091/mbc.E06-10-0972; PMID: 18172027
   PubMed Web of Science ®Google Scholar